Home » Adamis Pharma Vaccine Technology Receives European Patent
Adamis Pharma Vaccine Technology Receives European Patent
Adamis Pharmaceuticals has received a patent for TeloB-VAX technology, developed for cell-based cancer vaccines in Europe. The technology provides a method — somatic transgene immunization (STI) — to deliver a nucleic acid molecule such as DNA vaccine into B cells (a cell of the immune system).
PBR
PBR
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May